CV Sciences, Inc. vs TherapeuticsMD, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- TherapeuticsMD, Inc. is the larger company by market value: $23 M against $20 M for CV Sciences, Inc., 1.1 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 14, 2026 for TherapeuticsMD, Inc.). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
- CV Sciences, Inc. had more revenue: $14 M against $3 M for TherapeuticsMD, Inc., both in the year to December 2025.
- Both made a net loss: $1 M for CV Sciences, Inc. and $1 M for TherapeuticsMD, Inc.
- CV Sciences, Inc. keeps more of each dollar of sales: a net margin of -7.0% against -18.9% for TherapeuticsMD, Inc.
- TherapeuticsMD, Inc.'s revenue grew faster in its latest fiscal year: +71.6% against -12.2% for CV Sciences, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | CV Sciences, Inc. CVSI | TherapeuticsMD, Inc. TXMD · #23,958 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2010 | — |
| Size | ||
| Market cap | $20 M* | $23 M |
| Revenue | $14 M | $3 M |
| Net income | $-1 M | $-1 M▲ best |
| Employees | 44 | — |
| Valuation | ||
| Price to sales | — | 6.9× |
| Price to book | — | 0.8× |
| Profitability | ||
| Gross margin | 49.0% | — |
| Operating margin | -3.4%▲ best | -145.4% |
| Net margin | -7.0%▲ best | -18.9% |
| Return on equity | -58.7% | -2.1%▲ best |
| Growth | ||
| Revenue growth | -12.2% | 71.6%▲ best |
| Revenue growth, 3 years a year | -5.2% | — |
| Financial strength | ||
| Debt to equity | 1.1× | — |
| Interest cover | — | -439.0× |
| Cash | ||
| Free cash flow margin | -3.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Jan 2022; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, CV Sciences, Inc. or TherapeuticsMD, Inc.?
TherapeuticsMD, Inc. is the larger company by market value: $23 M against $20 M for CV Sciences, Inc., 1.1 times as much (market caps of Jan 7, 2022 for CV Sciences, Inc. and Oct 14, 2026 for TherapeuticsMD, Inc.). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, CV Sciences, Inc. or TherapeuticsMD, Inc.?
CV Sciences, Inc. had more revenue: $14 M against $3 M for TherapeuticsMD, Inc., both in the year to December 2025. Both made a net loss: $1 M for CV Sciences, Inc. and $1 M for TherapeuticsMD, Inc.
Which is more profitable, CV Sciences, Inc. or TherapeuticsMD, Inc.?
CV Sciences, Inc. keeps more of each dollar of sales: a net margin of -7.0% against -18.9% for TherapeuticsMD, Inc.
Which is growing faster, CV Sciences, Inc. or TherapeuticsMD, Inc.?
TherapeuticsMD, Inc.'s revenue grew faster in its latest fiscal year: +71.6% against -12.2% for CV Sciences, Inc.
More about CV Sciences, Inc.
More about TherapeuticsMD, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.